Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
5.14
+0.37 (7.76%)
Nov 13, 2026, 4:00 PM EST - Market closed
Impact BioMedical Revenue
Impact BioMedical had revenue of $21.00K in the quarter ending September 30, 2026, with 16.67% growth. This brings the company's total for the last twelve months to $38.00K, up 52.00% year-over-year. In the year 2025, Impact BioMedical had annual revenue of $32.00K. That makes Impact BioMedical the 46,751st largest company in the world by revenue and 7,014th in the United States.
Revenue (ttm)
$38.00K
Revenue Growth
+52.00%
P/S Ratio
1,155.66
Revenue / Employee
$19,000
Employees
2
Market Cap
43.91M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 50.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
IBO News
- 6 days ago - Impact BioMedical Quarterly report: Q3 2026 - Filings
- 19 days ago - Impact BioMedical Proxy statement: Proxy filing - Filings
- 7 weeks ago - Impact Biomedical Inc trading resumes - TheFly
- 7 weeks ago - Impact Biomedical Inc trading halted, volatility trading pause - TheFly
- 2 months ago - Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited) - GlobeNewsWire
- 2 months ago - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) - GlobeNewsWire
- 2 months ago - Impact BioMedical announces 1 for 12.62 reverse stock split - TheFly
- 2 months ago - Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd. - GlobeNewsWire